Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
40,9 CNY | +0,69 % | -9,17 % | -20,66 % |
Resumen de negocios
Número de empleados: 1 961
Ventas por actividad
CNY en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Drug
98,6
%
| 2 206 | 98,2 % | 2 342 | 98,6 % | +6,19 % |
Promotional Services
0,8
%
| 31 | 1,4 % | 19 | 0,8 % | -38,41 % |
Factory Rental
0,6
%
| 8 | 0,4 % | 14 | 0,6 % | +72,49 % |
Others
0,0
%
| 0 | 0,0 % | 0 | 0,0 % | +10,65 % |
Ventas por región
CNY en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 2 245 | 100,0 % | 2 376 | 100,0 % | +5,82 % |
Abroad
0,0
%
| 0 | 0,0 % | 0 | 0,0 % | +12,92 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jia Tong
CEO | Chief Executive Officer | 46 | 01/01/03 |
Lie Ming Ding
CEO | Chief Executive Officer | 60 | 07/01/03 |
Jian Xun Fan
DFI | Director of Finance/CFO | 52 | 01/01/16 |
Jiang Wan
COO | Chief Operating Officer | 56 | 01/04/11 |
Jia Bing Wang
CTO | Chief Tech/Sci/R&D Officer | 60 | 28/02/16 |
Jian Hao Shen
IRC | Investor Relations Contact | - | - |
Ling Xi Wu
SEC | Corporate Secretary | 41 | 24/09/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Lie Ming Ding
CEO | Chief Executive Officer | 60 | 07/01/03 |
Wei Wang
BRD | Director/Board Member | 57 | 22/11/19 |
Jia Tong
CEO | Chief Executive Officer | 46 | 01/01/03 |
Jiang Wan
COO | Chief Operating Officer | 56 | 01/04/11 |
Fei Wu
BRD | Director/Board Member | 47 | 27/11/17 |
Jian Xun Fan
DFI | Director of Finance/CFO | 52 | 01/01/16 |
Tian Xu
BRD | Director/Board Member | 62 | 17/10/22 |
Xin Qi Huang
BRD | Director/Board Member | 53 | 22/01/21 |
Jia Jia Xiao
BRD | Director/Board Member | 41 | 17/10/22 |
Rong Wang
BRD | Director/Board Member | 61 | 27/12/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 418 485 885 | 215 716 338 ( 51,55 %) | 0 | 51,55 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
C4 THERAPEUTICS, INC. 8.12% | 5 567 928 | 8.12% | 61 135 849 $ |
Información de la empresa
Betta Pharmaceuticals Co., Ltd.
355 Xingzhong Road Yuhang Economic & Tech Dev Zone
311100, Hangzhou
+
http://www.bettapharma.comSector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-20,66 % | 2368,35 M | |
+13,52 % | 9626,29 M | |
-7,87 % | 5371,28 M | |
+12,50 % | 4277,34 M | |
+18,09 % | 3711,64 M | |
+42,95 % | 2910,52 M | |
-19,01 % | 2535,77 M | |
+17,86 % | 1867,01 M | |
-0,50 % | 1644,13 M | |
-8,99 % | 1653,5 M |
- Bolsa
- Acciones
- Acción Betta Pharmaceuticals Co., Ltd. - Shenzhen S.E.
- Empresa Betta Pharmaceuticals Co., Ltd.